Guidelines for [[antithrombotic]] therapy for the treatment of [[venous thromboembolism]] (VTE), developed in 2001 by the Sixth [[American College of Chest Physicians]] (ACCP), state that patients with acute VTE should be treated with [[low-molecular-weight heparin]], unfractionated intravenous heparin, or adjusted-dose subcutaneous heparin